Literature DB >> 33717400

Extramedullary Plasmacytoma of the breast in a patient with Multiple Myeloma.

Stephen Vong1, Shannon Marisa Navarro1, Morgan Darrow2, Shadi Aminololama-Shakeri1.   

Abstract

Extramedullary plasmacytoma of the breast is rare. It is important to recognize the imaging findings and include it as a differential consideration in multiple myeloma patients with a breast mass. A 74-year-old woman undergoing chemotherapy for relapsed multiple myeloma presented with a palpable mass in her right breast. A screening mammogram four months prior was unremarkable. She underwent a diagnostic right mammogram which showed two well-circumscribed hyperdense masses. An ultrasound of the right breast showed mixed echogenic masses with indistinct margins and increased vascularity. Ultrasound guided biopsy confirmed the presence of an extramedullary plasmacytoma. A follow-up whole body PET/CT demonstrated an FDG-avid right breast mass with extensive osseous metastases. Copyright Journal of Radiology Case Reports.

Entities:  

Keywords:  Plasmacytoma; breast; mammography; multiple myeloma; ultrasound

Mesh:

Year:  2020        PMID: 33717400      PMCID: PMC7943045          DOI: 10.3941/jrcr.v14i12.4110

Source DB:  PubMed          Journal:  J Radiol Case Rep        ISSN: 1943-0922


  32 in total

1.  Plasmablastic plasmacytoma of the breast.

Authors:  Don K Le; David Metter; John R Krause
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

2.  Unusual malignant breast lesions: imaging-pathological correlations.

Authors:  Belgin Karan; Ayşin Pourbagher; Filiz Aka Bolat
Journal:  Diagn Interv Radiol       Date:  2011-09-17       Impact factor: 2.630

3.  Bilateral extramedullary plasmacytoma of the breast.

Authors:  Thomas Neuhaus; Thomas Hess
Journal:  Breast J       Date:  2014-03-27       Impact factor: 2.431

4.  A Case Report of a Breast Implant-Associated Plasmacytoma and Literature Review of Non-ALCL Breast Implant-Associated Neoplasms.

Authors:  Ahmed Sam Beydoun; Fernando Ovalle; Kristina Brannock; Ryan M Gobble
Journal:  Aesthet Surg J       Date:  2019-06-21       Impact factor: 4.283

5.  Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse.

Authors:  Ludek Pour; Sabina Sevcikova; Henrieta Greslikova; Renata Kupska; Petra Majkova; Lenka Zahradova; Viera Sandecka; Zdenek Adam; Marta Krejci; Petr Kuglik; Roman Hajek
Journal:  Haematologica       Date:  2013-09-13       Impact factor: 9.941

6.  Hematologic Malignancies Discovered on Investigation of Breast Abnormalities.

Authors:  Alaa Alsadi; Dianna Lin; Hussein Alnajar; Arlen Brickman; Colin Martyn; Paolo Gattuso
Journal:  South Med J       Date:  2017-10       Impact factor: 0.954

Review 7.  Insights on Multiple Myeloma Treatment Strategies.

Authors:  María-Victoria Mateos; Heinz Ludwig; Ali Bazarbachi; Meral Beksac; Joan Bladé; Mario Boccadoro; Michele Cavo; Michel Delforge; Meletios A Dimopoulos; Thierry Facon; Catarina Geraldes; Hartmut Goldschmidt; Roman Hájek; Markus Hansson; Krzysztof Jamroziak; Merav Leiba; Tamás Masszi; Larisa Mendeleeva; Michael O'Dwyer; Torben Plesner; Jesús F San-Miguel; Christian Straka; Niels W C J van de Donk; Kwee Yong; Samo Zver; Philippe Moreau; Pieter Sonneveld
Journal:  Hemasphere       Date:  2018-12-27

8.  Recurrence of extramedullary plasmacytoma of the breast.

Authors:  Khaled Majadob; Wesam Al-Sakkaf; Farouk Rezk; Kris Zegocki; Faris Al-Refaie
Journal:  Ecancermedicalscience       Date:  2013-05-28

9.  Bilateral breast plasmacytoma: a clinical case report.

Authors:  Thais Rodrigues da Cunha Fischer; Fabiana Higashi; Edvan de Queiroz Crusoe; Vania Tietsche de Moraes Hungria
Journal:  Rev Bras Hematol Hemoter       Date:  2016-03-25

10.  Non Secretory Multiple Myeloma With Extensive Extramedullary Plasmacytoma: A Diagnostic Dilemma.

Authors:  Soo Fin Low; Nor Hanani Mohd Tap; Thean Yean Kew; Chai Soon Ngiu; Radhika Sridharan
Journal:  Iran J Radiol       Date:  2015-07-22       Impact factor: 0.212

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.